Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
106.50    -2.50 (-2.29%)
Bid:
106.00
Ask:
107.50
Spread: 1.50 (1.415%)
Market Cap: £104.96m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Trading Update

16 May 2024 07:00

RNS Number : 6256O
Eurocell plc
16 May 2024
 

16 May 2024

EUROCELL PLC

("Eurocell" the "Group" or the "Company")

Trading Update

 

Eurocell plc, the market leading, vertically integrated UK manufacturer, recycler and distributor of PVC window, door and roofline products, provides the following update for the first four months of 2024, in advance of the Annual General Meeting ("AGM") later today.

 

Summary

Trading conditions in our key markets have remained challenging, with continuing macroeconomic uncertainty impacting activity levels in both the repair, maintenance and improvement ("RMI") and new build markets. However, we continue to focus on closely managing costs and cash flow and have seen some further reduction in raw material cost pricing in 2024. As a result, our expectations for underlying profit before tax for the year remain unchanged.

 

We are on track with the delivery of the early stages of our new strategy. Our balance sheet is strong and the actions we have taken, including those on costs and cash flow, position us well to benefit when our end markets recover.

 

Trading Performance

Group sales for the four months to 30 April 2024 were down 6%(1) on the prior year, with volume down 4%(1). Comparisons by division were as follows:

 

Sales to 30 April 2024

vs 2023(1)

Total Group

-6%

Profiles Division

-10%

Building Plastics Division

-4%

(1) On a trading day adjusted basis

 

Profiles - subdued RMI activity and a continuing weak new build market have resulted in sales volumes 9%(1) below 2023.

 

Building Plastics - although general RMI volumes in the branch network are down, sales include the initial benefit of good progress with our strategic initiatives for garden rooms, windows and doors, resulting in overall volumes level(1) with 2023. However, increased competition for limited demand continues to drive pressure on margins in the branch network.

 

There has been some moderation of input costs, particularly electricity (where we operate a rolling 12-month forward hedging policy for the majority of our requirements) and recycling infeed prices, and PVC resin prices have stabilised. We continue to see inflation elsewhere, including labour costs, which we have offset with selling price increases implemented towards the end of Q1 2024.

 

Capital Allocation

The Board is focused on enhancing shareholder returns and recognises the importance of our ordinary dividend. We will periodically consider supplementary distributions, whilst always seeking to maintain a strong financial position.

The £5 million share buyback programme (the "Buyback") announced on 23 January 2024 has progressed well. As of 14 May 2024, we had purchased 3.3 million ordinary shares of £0.001 each ("Shares") at a cash cost of £4.2 million. As previously announced, the first 642,000 Shares repurchased under the Buyback are held in treasury and will be used to satisfy employee share options over the next two years, with other Shares already purchased having been cancelled. All other Shares purchased under the Buyback in future will also be cancelled. The Buyback therefore reduces the share capital of the Company and enhances earnings per share.

 

Taking into account our strong balance sheet, expected organic investment needs and good cash management, the Board has taken the decision to extend the Buyback by up to a further £5 million, thereby increasing the maximum aggregate consideration to up to £10 million.

 

Eurocell has given irrevocable and non-discretionary instructions to Peel Hunt and Berenberg in relation to the Buyback, who will act as principal and make trading decisions concerning the timing of the purchases of Shares independently of the Company.

 

Assuming the applicable authority is granted at today's AGM, the maximum number of Shares which can be purchased under the Buyback following the conclusion of the AGM is 10,969,731.

 

The Buyback will continue to be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 (also as in force in the UK, from time to time, including, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as the applicable laws and regulations of the UK Financial Conduct Authority.

 

Save as set out herein, the Buyback will otherwise operate under the same terms as announced on 23 January 2024.

 

The Board will keep the Buyback under review and continue to assess it against market conditions and our capital allocation priorities. There is no guarantee that the Buyback will be implemented in full.

 

Board Changes

As previously announced, after nine years of service, Frank Nelson will step down from the Board at the conclusion of today's AGM and we would like to thank him for his significant contribution to the Group. Alison Littley will assume the role of Senior Independent Non-executive Director.

 

 

Enquiries:

Eurocell plc

Darren Waters, Chief Executive Officer +44 (0) 1773 842 105

Michael Scott, Chief Financial Officer +44 (0) 1773 842 140

Teneo

Nick de Bunsen +44 (0) 7825 575 258

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIGDUGBBDGSU
Date   Source Headline
18th May 20264:00 pmRNSDirector/PDMR Shareholding
14th May 20261:49 pmRNSResult of AGM
14th May 20267:00 amRNSTrading Update
1st May 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSLeadership Update - CFO Appointment
15th Apr 20267:00 amRNSPublication of 2025 Annual Report & Notice of AGM
23rd Mar 202610:15 amRNSDirector/PDMR Shareholding
19th Mar 202610:30 amRNSDirector/PDMR Shareholding
19th Mar 20267:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2025
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
17th Feb 20267:00 amRNSTransaction in Own Shares - Buyback Complete
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20261:00 pmRNSDirectorate changes
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSDirector/PDMR Shareholding
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSYear End Trading Update
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:00 pmRNSPurchase of Shares via Employee Benefit Trust
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.